LeMaitre Vascular (LeMaitre Vascular) Gross Profit

: $127.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

LeMaitre Vascular's gross profit for the three months ended in Dec. 2023 was $33.3 Mil. LeMaitre Vascular's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was $127.0 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. LeMaitre Vascular's gross profit for the three months ended in Dec. 2023 was $33.3 Mil. LeMaitre Vascular's Revenue for the three months ended in Dec. 2023 was $48.9 Mil. Therefore, LeMaitre Vascular's Gross Margin % for the quarter that ended in Dec. 2023 was 68.05%.

LeMaitre Vascular had a gross margin of 68.05% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of LeMaitre Vascular was 70.59%. The lowest was 64.89%. And the median was 68.12%.

Warning Sign:

LeMaitre Vascular Inc gross margin has been in long-term decline. The average rate of decline per year is -1.3%.

LeMaitre Vascular Gross Profit Historical Data

The historical data trend for LeMaitre Vascular's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LeMaitre Vascular Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Profit

Get a 7-Day Free Trial

79.85

84.62

101.38

104.90

127.05

LeMaitre Vascular Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross Profit	Get a 7-Day Free Trial															26.05	30.88	32.09	30.82	33.27

Competitive Comparison

For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LeMaitre Vascular Gross Profit Distribution

For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Gross Profit distribution charts can be found below:

* The bar in red indicates where LeMaitre Vascular's Gross Profit falls into.

LeMaitre Vascular Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

LeMaitre Vascular's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	193.484	-	66.435
	=	127.0

LeMaitre Vascular's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	48.883	-	15.618
	=	33.3

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $127.0 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

LeMaitre Vascular's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	33.3	/	48.883
	=	68.05 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

LeMaitre Vascular (NAS:LMAT) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

LeMaitre Vascular had a gross margin of 68.05% for the quarter that ended in Dec. 2023 => Durable competitive advantage

LeMaitre Vascular Gross Profit Related Terms

Thank you for viewing the detailed overview of LeMaitre Vascular's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

LeMaitre Vascular (LeMaitre Vascular) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LeMaitre Vascular Inc (NAS:LMAT) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

LHU:Germany

Address

63 Second Avenue, Burlington, MA, USA, 01803

Website

https://www.lemaitre.com

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Executives

George W Lemaitre	director, 10 percent owner, officer: Chairman, President and CEO	342 BUNKER HILL STREET, #2B, CHARLESTOWN MA 02129
Bridget A Ross	director	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
John A Roush	director	C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730-1409
Lawrence J Jasinski	director	SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760
David B Roberts	director, officer: CFO and Director	55 BRADFORD STREET, NEEDHAM MA 02492
Trent G Kamke	officer: Senior V. P., Operations	61 WILLOWDEAN AVENUE, WEST ROXBURY MA 02132
Martha Shadan	director	9201 W BROADWAY AVE, #650, MINNEAPOLIS MN 55445
Pellegrino Joseph P Jr	officer: Executive V.P. Finance	68 BEACON STREET, BOSTON MA 02108
Michael H Thomas	director	P.O. BOX 2207, NOKOMIS FL 34274-2207
Peter R Gebauer	officer: President, International OP	AM WALDFELD 17, BAD SODEN 2M 65812
Michael T Wijas	officer: VP of Sales, The Americas	C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON MA 01803
Lemaitre Cornelia W	director, officer: V.P., Human Resources,Director	8 SUNSET ROCK ROAD, ANDOVER MA 01810
Russell D Hays	director	C/O BIOSOURCE INTERNATIONAL INC, 542 FLYNN RD, CAMARILLO CA 93012
Robert V Linden	officer: VP, North American Sales	236 WOODEN BRIDGE ROAD, HOLLAND PA 18966
Thorndike William N Jr	director	HOUSATONIC PARTNERS, 800 BOYLSTON STREET, SUITE 2220, BOSTON MA 02199